![Javad Shahidi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Javad Shahidi
Plus aucun poste en cours
Fortune : 1 M $ au 31/05/2024
Profil
Javad Shahidi worked as Vice President-Global Research & Development at Daiichi Sankyo, Inc. from 2019 to 2022.
He also worked as Chief Medical Officer at Centessa Pharmaceuticals Plc in 2022.
Prior to his professional experience, he earned a graduate degree from McGill University and a doctorate degree from Shahid Beheshti University of Medical Sciences.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
03/10/2022 | 158 932 ( 0,18% ) | 1 M $ | 31/05/2024 |
Anciens postes connus de Javad Shahidi
Sociétés | Poste | Fin |
---|---|---|
CENTESSA PHARMACEUTICALS PLC | Directeur Technique/Scientifique/R&D | 14/10/2022 |
Daiichi Sankyo, Inc.
![]() Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Directeur Technique/Scientifique/R&D | 01/03/2022 |
Formation de Javad Shahidi
McGill University | Graduate Degree |
Shahid Beheshti University of Medical Sciences | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CENTESSA PHARMACEUTICALS PLC | Health Technology |
Entreprise privées | 1 |
---|---|
Daiichi Sankyo, Inc.
![]() Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |